AI assistant
Mankind Pharma Limited — Call Transcript 2025
Nov 6, 2025
61869_rns_2025-11-06_4eb41594-8aa8-4850-bb26-8d515cb9c7c5.pdf
Call Transcript
Open in viewerOpens in your device viewer
==> picture [559 x 53] intentionally omitted <==
==> picture [559 x 55] intentionally omitted <==
November 6, 2025
BSE Limited
P J Towers, Dalal Street, Mumbai – 400 001
Scrip Code: 543904
National Stock Exchange of India Limited Exchange Plaza, C-1, Block G, Bandra Kurla Complex, Bandra (E), Mumbai – 400 051
Symbol: MANKIND
Dear Sir/ Madam,
Subject: Investor Conference Call for Q2 & H1 FY26 – Audio Recording
Pursuant to Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and further to our intimation dated October 29, 2025 under subject ‘Intimation of Investor Conference Call for Q2 & H1 FY26 with Senior Management of Mankind Pharma Limited (“the Company”)’ , the audio recording of the Call held today i.e. November 6, 2025 is available on the website of the Company at: https://www.mankindpharma.com/wpcontent/uploads/2025/11/Q2FY26-Earnings-Call-Audio.mp3.
You are requested to kindly take the same on records.
Thanking You,
Yours Faithfully,
For Mankind Pharma Limited
Digitally signed by HITESH HITESH KUMAR JAIN KUMAR JAIN Date: 2025.11.06 19:48:12 +05'30' Hitesh Kumar Jain Company Secretary & Compliance Officer
==> picture [557 x 60] intentionally omitted <==